MétaCan
Menu
Back to cohort

Rosiglitazone and Ethinyl Estradiol/Cyproterone Acetate as Single and Combined Treatment of Overweight Women with Polycystic Ovary Syndrome and Insulin Resistance

2006· article· en· W2326909691 on OpenAlexaff
A. Lemay, K S. Dodin, Lucile Turcot, F D ch ne, J. C. Forest

Bibliographic record

VenueObstetrical & Gynecological Survey · 2006
Typearticle
Languageen
FieldMedicine
TopicOvarian function and disorders
Canadian institutionsUniversité LavalHôpital Saint-François d'Assise
Fundersnot available
KeywordsMedicinePolycystic ovaryCyproterone acetateInsulin resistanceInternal medicineEndocrinologyRosiglitazonehirsutismCyproteroneInsulinHomeostatic model assessmentQuantitative insulin sensitivity check indexTestosterone (patch)Free androgen indexAndrogenHormoneInsulin sensitivity

Abstract

fetched live from OpenAlex

Insulin resistance (IR) has been reported in as many as 50% of women with polycystic ovary syndrome (PCOS) and in up to 95% of those who are obese. Today, insulin sensitizers are given to many of these affected women. This study examined the comparative effectiveness of rosiglitazone, a thiazolidinedione, and an oral contraceptive combining ethinyl estradiol (EE) with cyproterone acetate (CPA). Participants were 28 obese women ranging in age from 18 to 45 years who met criteria for PCOS and who still had high insulin levels despite 4 months of dietary treatment. They were randomly assigned to 6 months of treatment with either 4 mg rosiglitazone daily or a combination of 35 μg EE and 2 mg CPA given on 21 days per 28-day cycle. Each group then received both treatments for 6 months longer. Women in both treatment groups had normal blood glucose levels throughout the study. Rosiglitazone decreased insulin levels, indices of IR (homeostasis model assessment, quantitative sensitivity check index, and the area under the curve for insulin in response to an oral glucose tolerance test [OGTT]). Drug effects on lipids, androgens, and hirsutism were limited. Treatment with EE/CPA did not alter insulin levels or the response to an OGTT. It did increase levels of high-density lipoprotein cholesterol and triglycerides while decreasing androgen levels and hirsutism. Similar findings were obtained when both treatments were given for 6 months. Only EE/CPA significantly lowered hirsutism scores, as shown in Figure 1 in which patients in group A were those randomized to receive rosiglitazone initially and patients in group B began treatment by taking EE/CPA. There were no serious side effects.Fig. 1: Means ±SEM of hirsutism score at baseline, end of single treatment (month 6) and end of combined treatments (month 12). *P < 0.05 month 6 versus month 0; §§P < 0.01 month 12 versus month 6; ¶¶P < 0.01 month 12 versus month 0. From: Lemay et al., Rosiglitazone and Ethinyl Estradiol/Cyproterone Acetate as Single and Combined Treatment of Overweight Women with Polycystic Ovary Syndrome and Insulin Resistance. Hum Reprod 2005; Doi: 10.1093/humrep/dei312 © European Society of Human Reproduction and Embryology. Reproduced by permission of Oxford University Press/Human Reproduction.This approach to obese women with PCOS and insulin resistance might be particularly appropriate for women who request an oral contraceptive.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.071
Threshold uncertainty score0.713

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.232
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueObstetrical & Gynecological SurveySame topicOvarian function and disordersFrench-language works237,207